2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤) : 2022-05-28±³À°ÀÏÀÚ : 2022-05-28
±³À°Àå¼Ò : ÇѾç´ëÇб³ HIT ´ëȸÀǽÇ
±³À°ÁÖÁ¦ :
2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤)ÁÖÃÖ±â°ü : ´ëÇѼҾư¨¿°ÇÐȸ
´ã´çÀÚ : ±è¿µ¶õ
¿¬¶ôó : 02-3478-1668
À̸ÞÀÏ :
kspid@kspid.or.kr ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 1Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í ȸ¿ø: 40,000¿øºñȸ¿ø: 60,000¿øÀü°øÀÇ ¹× Çлý: 10,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 10:00~10:30 Recent advances in prevention of RSV in young infants À±±â¿í(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 10:30~11:00 Advances in development of Influenza vaccines ±èÀ±°æ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 11:00~11:30 Prevention strategies for CMV infection ÀÌÁø¾Æ(¿ï»êÀÇ´ë)
±âŸ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 11:30~12:00 ÃÑȸ ()
½Ä»ç 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 12:00~13:00 Áᫎ ()
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 13:00~13:40 Past, present, and future of mRNA vaccines Á¶´ë¼±/TBD(ÀüºÏÀÇ´ë/Moderna)
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 13:40~14:20 COVID-19 in children and pregnant women in Japan Kensuke Shoji(National Center for Child Health and Development)
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 14:20~15:00 Clinical features of COVID-19 in children in Korea Çѹ̼±(¼¿ïÀÇ´ë)
ÈÞ½Ä 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 15:00~15:20 ÈÞ½Ä ()
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 15:20~15:50 Issues on COVID-19 vaccines in children: effectiveness, safety and goals ÃÖ¿µÁØ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 15:50~16:20 Surveillance during the COVID-19 pandemic: modeling and monitoring Á¤ÀçÈÆ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 16:20~16:50 Reflecting on infection control measures in COVID-19: what was necessary and what was not? Á¶Çý°æ(°¡ÃµÀÇ´ë)
±âŸ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀÇ½Ç 16:50~17:00 Çмú³í¹®»ó ¹× PIV ¿ì¼ö ½É»çÀ§¿ø»ó ¼ö»ó ()